Martha J. Carter, Chief Regulatory Officer & SVP at Aegerion Pharmaceuticals, Inc. (AEGR), bought 500 shares at $27.81 ($14K) on 2013-01-23, disclosed to the SEC on 2013-01-24.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| ALBO | SELL | 2022-10-25 | $2K | — | Filing → |
| ALBO | SELL | 2022-07-25 | $3K | — | Filing → |
| ALBO | SELL | 2022-04-25 | $3K | — | Filing → |